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Abstract
Menopausal health is important since this stage of life is not to be avoided. A recent article in BMC
Women's Health from the Estonian Postmenopausal Hormone Therapy trial has concluded that
quality of life is not related to hormonal therapy use. The commentary article discusses this finding
and considers other factors related to symptoms and quality of life during menopause. Important
factors known to affect hot flushes and quality of life are smoking and high body weight. Since both
these factors are modifiable, menopause is a suitable area for health promotion. However, evidence
concerning lifestyle changes in symptom relief or increase of quality of life is weak. More trials in
this area are needed before women may consider non-pharmacological treatment of symptoms as
a reliable option for menopausal symptom cure.
Menopausal symptoms are common
Menopause is not avoided by any woman but frequency
and severity of menopausal symptoms vary. A recent arti-
cle published in BMC Women's Health by Veerus et al [1]
reported that quality of life did not depend on hormonal
therapy (HT) use, although HT users reported less hot
flushes and sleeping problems. A number of studies have
reported the prevalence of menopausal symptoms among
mid-aged women. These studies are based on different
populations, questions and severity of symptoms. Typical
menopausal symptoms are vasomotor symptoms (hot
flushes), vaginal dryness [2-4] and sleep disturbances [5].
The probability of other symptoms is higher if the woman
has vasomotor symptoms [6,7]. Cross-sectional surveys
among women of different ages show that hot flushes are
most common soon after menopause, but they occur even
after 10 years [4]. According to a Dutch cross-sectional
survey, a third of menopausal women have severe vaso-
motor symptoms and 7% have symptoms even 10 years
after the menopause [6,8]. About half of 50-year old and
one quarter of 60-year old Swedish women experienced
hot flushes [9]. However, not all women consider hot
flushes disturbing [6,8-11] and the question of severity
remains to be solved.
Hormone therapy and quality of life
During recent years hormonal therapy (HT) has been
introduced as a solution to menopausal symptoms. The
Women's Health Initiative's (WHI) study results [12]
showed the pros and cons of HT among women aged 65
and over, but HT is known to be an effective relief to hot
flushes. Veerus et al's study [1] was based on the Estonian
Postmenopausal Hormone Therapy (EPHT) trial, which
included 1823 women aged 50 to 64 who were followed
on average for 3.6 years. HT users reported fewer hot
flushes, sweating and sleep problems but did not have
better quality of life. The Women's Health Initiative trial
reported similar findings to that of Veerus et al [13] but in
the Heart and Estrogen/Progestin Replacement Study
(HERS) trial HT improved quality of life for women with
menopausal symptoms [14]. Both HERS and WHI studies
had shorter follow-up times than EPHT, which, in addi-
tion to cultural factors, explains part of the contradictory
result. However, the conclusion is now that quality of life
Published: 18 May 2009
BMC Women's Health 2009, 9:13 doi:10.1186/1472-6874-9-13
Received: 16 October 2008
Accepted: 18 May 2009
This article is available from: http://www.biomedcentral.com/1472-6874/9/13
© 2009 Luoto; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Women's Health 2009, 9:13 http://www.biomedcentral.com/1472-6874/9/13
Page 2 of 3
(page number not for citation purposes)
cannot be guaranteed with HT use, it is necessary to con-
sider other issues. It is known that menopausal transition
does not intrinsically lead to poor general quality of life
(OQL) or satisfaction in life [15]. A crucial factor is pres-
ence of vasomotor symptoms, which are clearly related to
poor QOL [16]. The result of the Veerus et al study [1] was
important, since based on these earlier findings it was
expected that quality of life would increase if vasomotor
symptoms are decreased.
Lifestyle and menopausal symptoms
Early onset of menopause [17] as well as long perimeno-
pausal phase [18] are risk factors for deteriorated well-
being in menopause. Other risk factors for increased expe-
rience of hot flushes are smoking and high body mass
index (BMI). High BMI (at least 25 kg/m2) has been asso-
ciated with the risk of any or daily hot flushes in many
recent studies [19-22]. All previous studies concluded that
associations between hot flushes and BMI were found
only among pre- or perimenopausal women, but not
among postmenopausal women. Associations between
hot flushes and smoking have been shown in many earlier
studies [20,23,24].
The quality of life of smokers and persons with high BMI
is known to be low and an increase in hot flushes does not
alleviate their situation, quite the opposite. There is a clear
need for general health promotion and obesity prevention
during the menopausal age in order to increase quality of
life. Lifestyle changes, such as increasing physical activity,
is one alternative to HT. Evidence on reducing cardiovas-
cular disease by physical activity exists especially among
postmenopausal women [25,26]. However, evidence on
whether physical activity reduces menopausal symptoms
is still inconclusive. Earlier studies have suggested physi-
cal activity may act as a possible tool for decreasing some
menopausal vasomotor symptoms [20,27]. At least main-
taining or increasing physical activity in SWAN (Study of
Women across Nation) cohort resulted in maintenance or
decrease of body weight [28]. Only a few randomized
clinical trials on exercise and menopausal symptom
reduction have been performed [27,29]. Wilbur et al [27]
concluded that women in the exercise intervention group
had fewer vasomotor symptoms and improved sleep as
compared to controls. Aiello et al [29] study showed an
increase in hot flash severity and decreased risk of mem-
ory problems among the intervention group women com-
pared to controls. Both studies were quite small and not
all participants had symptoms at baseline. Randomized
clinical trials are needed to further address the effect of
physical activity for symptoms experienced by midlife
women.
Menopausal health promotion – a future 
challenge
Menopausal transition may make women more aware of
future health risks due to increased symptomatology and
help-seeking behaviour. Motivation for health promotion
may be further strengthened if women perceive life-style
modifications as an alternative, non-pharmacological,
way of managing menopausal symptoms. However, more
evidence on effectiveness and efficacy of lifestyle changes,
especially exercise, on decreasing hot flushes and increas-
ing quality of life is urgently needed. In the future, meno-
pause may act as a window of opportunity for health
promotion and life-modifications. Studies from rand-
omized trials such as Veerus et al [1] are necessary before
taking the next steps in menopausal women's health.
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